In 2020, Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in Chemistry 2020 for discovering CRISPR/Cas9 which can be used to change the DNA of living organisms with high precision. This technology has revolutionized genetic engineering and therapies, offering unprecedented opportunities to advance our understanding of genetic diseases, develop novel therapies, and potentially treat and cure previously intractable conditions.
In this CAS InsightsTM report, we examine data from the CAS Content CollectionTM to highlight the latest advances and developments in CRISPR technology, with a focus on its potential in medicine.
To learn more about CRISPR therapeutics, see our publication at a pre-print server.
